Celltrion Launches Zymfentra Media Campaign in the U.S.
Celltrion announced on the 27th that it has launched a media campaign in the U.S. for "Zymfentra," the world’s only infliximab subcutaneous (SC) formulation for treating autoimmune diseases. The campaign…